, Volume 8, Issue 3, pp 195–200 | Cite as

Association of progesterone receptor with migraine-associated vertigo

  • Hane Lee
  • Lauren Sininger
  • Joanna C. Jen
  • Yoon-Hee Cha
  • Robert W. Baloh
  • Stanley F. NelsonEmail author
Original Article


While migraine has been demonstrated to be familial and have genetic contributions, genome-wide linkage analyses and candidate gene studies have highlighted that migraine is genetically complex. Despite substantial efforts, no consistent replication of linkage or association has been reported for common migraine syndromes. Among the candidate genes tested for association with migraine by several groups were female sex hormone genes based on the observation of a much higher incidence of migraine in females. Migraine-associated vertigo (MAV) is a migraine syndrome also much more common in females than males. Because MAV is less common in the general population than migraine or migraine with aura, it may be a better migraine syndrome to detect susceptibility alleles. In this study, we tested the association of two female hormonal genes, progesterone receptor (PGR) and estrogen receptor (ESR1), which were previously reported to be associated with migraine in women. We typed 150 MAV subjects and 145 genomic matched control subjects. One SNP (rs1042838) within PGR, which is in high linkage disequilibrium with the functional PROGINS variant, was significantly associated with MAV (p = 0.0007). Two SNPs (rs2228480 and rs1801132) within ESR1 demonstrated no significant association. No synergistic effect between ESR1 variants and PGR variants was identified.


Migraine-associated vertigo Progesterone receptor PROGINS Association 



We are grateful to the patients and their families for participating in this research study. We thank S. L. Stoddart for the sample preparation. Genotyping was performed with the assistance of the UCLA Southern California Genotyping Consortium (SCGC). We thank the members of the Nelson Lab for the guidance and input. This study was supported by a program project grant NIH/NIDCD P50 DC 05224.

Conflict of interest statement

The authors declare no competing interests.


  1. 1.
    Stewart WF, Bigal ME, Kolodner K, Dowson A, Liberman JN, Lipton RB (2006) Familial risk of migraine: variation by proband age at onset and headache severity. Neurology 66:344–348CrossRefPubMedGoogle Scholar
  2. 2.
    Stewart WF, Staffa J, Lipton RB, Ottman R (1997) Familial risk of migraine: a population-based study. Ann Neurol 41:166–172CrossRefPubMedGoogle Scholar
  3. 3.
    Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267:64–69CrossRefPubMedGoogle Scholar
  4. 4.
    Sheffield RE (1998) Migraine prevalence: a literature review. Headache 38:595–601CrossRefPubMedGoogle Scholar
  5. 5.
    Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 12:221–228 (discussion 186)CrossRefPubMedGoogle Scholar
  6. 6.
    Lipton RB, Stewart WF (1997) Prevalence and impact of migraine. Neurol Clin 15:1–13CrossRefPubMedGoogle Scholar
  7. 7.
    Kelman L (2006) Migraine changes with age: IMPACT on migraine classification. Headache 46:1161–1171CrossRefPubMedGoogle Scholar
  8. 8.
    De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192–196CrossRefPubMedGoogle Scholar
  9. 9.
    Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552CrossRefPubMedGoogle Scholar
  10. 10.
    Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hamalainen E, Broas P, Joslyn G, Hovatta I, Hiekkalinna T, Kaprio J, Ott J, Cantor RM, Zwart JA, Ilmavirta M, Havanka H, Farkkila M, Peltonen L, Palotie A (2002) A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet 70:652–662CrossRefPubMedGoogle Scholar
  11. 11.
    Soragna D, Vettori A, Carraro G, Marchioni E, Vazza G, Bellini S, Tupler R, Savoldi F, Mostacciuolo ML (2003) A locus for migraine without aura maps on chromosome 14q21.2–q22.3. Am J Hum Genet 72:161–167CrossRefPubMedGoogle Scholar
  12. 12.
    Nyholt DR, Morley KI, Ferreira MA, Medland SE, Boomsma DI, Heath AC, Merikangas KR, Montgomery GW, Martin NG (2005) Genomewide significant linkage to migrainous headache on chromosome 5q21. Am J Hum Genet 77:500–512CrossRefPubMedGoogle Scholar
  13. 13.
    Lea RA, Nyholt DR, Curtain RP, Ovcaric M, Sciascia R, Bellis C, Macmillan J, Quinlan S, Gibson RA, McCarthy LC, Riley JH, Smithies YJ, Kinrade S, Griffiths LR (2005) A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 6:67–72CrossRefPubMedGoogle Scholar
  14. 14.
    Carlsson A, Forsgren L, Nylander PO, Hellman U, Forsman-Semb K, Holmgren G, Holmberg D, Holmberg M (2002) Identification of a susceptibility locus for migraine with and without aura on 6p12.2–p21.1. Neurology 59:1804–1807CrossRefPubMedGoogle Scholar
  15. 15.
    Cader ZM, Noble-Topham S, Dyment DA, Cherny SS, Brown JD, Rice GP, Ebers GC (2003) Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 12:2511–2517CrossRefPubMedGoogle Scholar
  16. 16.
    Bjornsson A, Gudmundsson G, Gudfinnsson E, Hrafnsdottir M, Benedikz J, Skuladottir S, Kristjansson K, Frigge ML, Kong A, Stefansson K, Gulcher JR (2003) Localization of a gene for migraine without aura to chromosome 4q21. Am J Hum Genet 73:986–993CrossRefPubMedGoogle Scholar
  17. 17.
    Aragones JM, Fortes-Rego J, Fuste J, Cardozo A (1993) Migraine: an alternative in the diagnosis of unclassified vertigo. Headache 33:125–128CrossRefPubMedGoogle Scholar
  18. 18.
    Bayazit Y, Yilmaz M, Mumbuc S, Kanlikama M (2001) Assessment of migraine-related cochleovestibular symptoms. Rev Laryngol Otol Rhinol (Bord) 122:85–88Google Scholar
  19. 19.
    Brantberg K, Trees N, Baloh RW (2005) Migraine-associated vertigo. Acta Otolaryngol 125:276–279CrossRefPubMedGoogle Scholar
  20. 20.
    Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetiser S, Aydogan B (1997) Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 106:182–189PubMedGoogle Scholar
  21. 21.
    Cutrer FM, Baloh RW (1992) Migraine-associated dizziness. Headache 32:300–304CrossRefPubMedGoogle Scholar
  22. 22.
    Dieterich M, Brandt T (1999) Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 246:883–892CrossRefPubMedGoogle Scholar
  23. 23.
    Kayan A, Hood JD (1984) Neuro-otological manifestations of migraine. Brain 107 (4):1123–1142CrossRefPubMedGoogle Scholar
  24. 24.
    Kuritzky A, Ziegler DK, Hassanein R (1981) Vertigo, motion sickness and migraine. Headache 21:227–231CrossRefPubMedGoogle Scholar
  25. 25.
    Lanzi G, Balottin U, Fazzi E, Tagliasacchi M, Manfrin M, Mira E (1994) Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia 14:458–460CrossRefPubMedGoogle Scholar
  26. 26.
    Mira E, Piacentino G, Lanzi G, Balottin U, Fazzi E (1984) Benign paroxysmal vertigo in childhood: a migraine equivalent. ORL J Otorhinolaryngol Relat Spec 46:97–104PubMedGoogle Scholar
  27. 27.
    Moretti G, Manzoni GC, Caffarra P, Parma M (1980) “Benign recurrent vertigo” and its connection with migraine. Headache 20:344–346CrossRefPubMedGoogle Scholar
  28. 28.
    Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56:436–441PubMedGoogle Scholar
  29. 29.
    Neuhauser HK, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, Lempert T (2006) Migrainous vertigo: prevalence and impact on quality of life. Neurology 67:1028–1033CrossRefPubMedGoogle Scholar
  30. 30.
    Savundra PA, Carroll JD, Davies RA, Luxon LM (1997) Migraine-associated vertigo. Cephalalgia 17:505–510 (discussion 487)CrossRefPubMedGoogle Scholar
  31. 31.
    Stahl JS, Daroff RB (2001) Time for more attention to migrainous vertigo? Neurology 56:428–429PubMedGoogle Scholar
  32. 32.
    von Brevern M, Ta N, Shankar A, Wiste A, Siegel A, Radtke A, Sander T, Escayg A (2006) Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 46:1136–1141CrossRefGoogle Scholar
  33. 33.
    Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR (2005) Investigation of hormone receptor genes in migraine. Neurogenetics 6:17–23CrossRefPubMedGoogle Scholar
  34. 34.
    Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR (2004) The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 5:129–133CrossRefPubMedGoogle Scholar
  35. 35.
    Oterino A, Pascual J, Ruiz de Alegria C, Valle N, Castillo J, Bravo Y, Gonzalez F, Sanchez-Velasco P, Cayon A, Leyva-Cobian F, Alonso-Arranz A, Munoz P (2006) Association of migraine and ESR1 G325C polymorphism. Neuroreport 17:61–64CrossRefPubMedGoogle Scholar
  36. 36.
    De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ (2002) A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 99:12263–12268CrossRefPubMedGoogle Scholar
  37. 37.
    Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BA, Dunning AM (2006) Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiol Biomarkers Prev 15:675–682CrossRefPubMedGoogle Scholar
  38. 38.
    Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC (2005) Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 97:51–59PubMedCrossRefGoogle Scholar
  39. 39.
    Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW (2005) Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol 161:442–451CrossRefPubMedGoogle Scholar
  40. 40.
    Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR (2001) Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 95:271–275CrossRefPubMedGoogle Scholar
  41. 41.
    Hsiao WC, Young KC, Lin SL, Lin PW (2004) Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res 6:R180–R186CrossRefPubMedGoogle Scholar
  42. 42.
    Vasconcelos A, Medeiros R, Veiga I, Pereira D, Carrilho S, Palmeira C, Azevedo C, Lopes CS (2002) Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis. Breast J 8:226–229CrossRefPubMedGoogle Scholar
  43. 43.
    Fan JB, Chee MS, Gunderson KL (2006) Highly parallel genomic assays. Nat Rev Genet 7:632–644CrossRefPubMedGoogle Scholar
  44. 44.
    Nielsen DM, Ehm MG, Weir BS (1998) Detecting marker-disease association by testing for Hardy–Weinberg disequilibrium at a marker locus. Am J Hum Genet 63:1531–1540CrossRefPubMedGoogle Scholar
  45. 45.
    Moskvina V, Holmans P, Schmidt KM, Craddock N (2005) Design of case-controls studies with unscreened controls. Ann Hum Genet 69:566–576CrossRefPubMedGoogle Scholar
  46. 46.
    Colson NJ, Lea RA, Quinlan S, Griffiths LR (2006) No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet 7:12CrossRefPubMedGoogle Scholar
  47. 47.
    Ophoff RA, van Eijk R, Sandkuijl LA, Terwindt GM, Grubben CP, Haan J, Lindhout D, Ferrari MD, Frants RR (1994) Genetic heterogeneity of familial hemiplegic migraine. Genomics 22:21–26CrossRefPubMedGoogle Scholar
  48. 48.
    Kallela M, Wessman M, Havanka H, Palotie A, Farkkila M (2001) Familial migraine with and without aura: clinical characteristics and co-occurrence. Eur J Neurol 8:441–449CrossRefPubMedGoogle Scholar
  49. 49.
    Oedegaard KJ, Angst J, Neckelmann D, Fasmer OB (2005) Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headaches Pain 6:378–386CrossRefGoogle Scholar
  50. 50.
    Eriksen MK, Thomsen LL, Olesen J (2006) Implications of clinical subtypes of migraine with aura. Headache 46:286–297CrossRefPubMedGoogle Scholar
  51. 51.
    Agoulnik IU, Tong XW, Fischer DC, Korner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG (2004) A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab 89:6340–6347CrossRefPubMedGoogle Scholar
  52. 52.
    Donaldson CJ, Crapanzano JP, Watson JC, Levine EA, Batzer MA (2002) PROGINS Alu insertion and human genomic diversity. Mutat Res 501:137–141PubMedGoogle Scholar
  53. 53.
    Sullivan PF (2007) Spurious genetic associations. Biol Psychiatry 61:1121–1126CrossRefPubMedGoogle Scholar
  54. 54.
    Kaunisto MA, Kallela M, Hamalainen E, Kilpikari R, Havanka H, Harno H, Nissila M, Sako E, Ilmavirta M, Liukkonen J, Teirmaa H, Tornwall O, Jussila M, Terwilliger J, Farkkila M, Kaprio J, Palotie A, Wessman M (2006) Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 26:1462–1472CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Hane Lee
    • 1
  • Lauren Sininger
    • 2
  • Joanna C. Jen
    • 2
  • Yoon-Hee Cha
    • 2
  • Robert W. Baloh
    • 2
    • 3
  • Stanley F. Nelson
    • 1
    • 4
    • 5
    Email author
  1. 1.Department of Human GeneticsUniversity of California, Los AngelesLos AngelesUSA
  2. 2.Department of NeurologyUniversity of California, Los AngelesLos AngelesUSA
  3. 3.Department of SurgeryUniversity of California, Los AngelesLos AngelesUSA
  4. 4.Division of Child and Adolescent Psychiatry, Department of Psychiatry and Biobehavioral SciencesUCLA School of Medicine, University of California, Los AngelesLos AngelesUSA
  5. 5.Los AngelesUSA

Personalised recommendations